Zydus Lifesciences Bolsters US Specialty Portfolio with ₹1,570 Crore Assertio Acquisition
In a major move to expand its international footprint, Indian pharmaceutical giant Zydus Lifesciences has announced the acquisition of U.S.-based Assertio Holdings. The deal, valued at approximately $166.4 million—roughly 1,570 crore rupees—is a strategic step to solidify Zydus’ presence in the wor...
